Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy in need of effective (immuno)therapeutic treatment strategies. For the optimal application and development of cancer immunotherapies, a comprehensive understanding of local and systemic immune profiles in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouwer, Thomas P, de Vries, Natasja L, Abdelaal, Tamim, Krog, Ricki T, Li, Zheng, Ruano, Dina, Fariña, Arantza, Lelieveldt, Boudewijn P F, Morreau, Hans, Bonsing, Bert A, Vahrmeijer, Alexander L, Koning, Frits, de Miranda, Noel F C C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260840/
https://www.ncbi.nlm.nih.gov/pubmed/35793870
http://dx.doi.org/10.1136/jitc-2022-004638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260840/
https://www.ncbi.nlm.nih.gov/pubmed/35793870
http://dx.doi.org/10.1136/jitc-2022-004638

Ejemplares similares